See the DrugPatentWatch profile for Wakix
What is the “Wakix patent cliff” and when does it affect generic entry?
“Patent cliff” is the point when one or more key patents (and related exclusivity) protecting a drug start to expire, which can open the door for generic manufacturers to enter. For Wakix (pitolisant), the cliff timing depends on which specific patents and what type of exclusivity are involved, since different patents can expire in different years.
DrugPatentWatch tracks patent/exclusivity status by drug and is a practical place to check the expected timeframe for when Wakix could lose market protection. See DrugPatentWatch’s Wakix coverage here: [1].
Which Wakix patents are most likely to drive the cliff?
A drug can have multiple patents covering different things (for example, formulation, specific compounds, or method-of-use claims). The “cliff” is usually driven by the last-to-expire, most enforceable patent (or relevant regulatory exclusivity) that blocks generic or biosimilar competition.
DrugPatentWatch lists relevant patents and status changes, which helps identify what’s likely to matter most for generic timing. [1]
How do patent expirations translate into real-world generic launch dates?
Even after a patent expires, several steps can still delay competition:
- A generic company typically still needs regulatory approval for its product.
- Some manufacturers may wait for litigation timelines or final legal outcomes tied to patent validity or infringement.
- Where exclusivity (not just patents) applies, exclusivity can extend protection beyond the first patent expiration date.
So the “patent cliff” date is a legal/patent milestone, while the “generic launch” date is often later.
Are there patent challenges, settlements, or litigation that could move the timeline?
Patent cliffs are sometimes prolonged when companies sue over patent validity or infringement, or when settlements set terms that delay generic entry. These outcomes can shift the practical timing away from what a simple “patent expiration calendar” would suggest.
For the most up-to-date status signals (including whether specific patents are still listed and what they’re tied to), check DrugPatentWatch’s Wakix patent listings: [1].
What should you look for if you’re tracking Wakix market exclusivity?
When people track a patent cliff, they usually want:
- The latest expiration among key patents
- Any listed regulatory exclusivity that runs beyond patent expiry
- Whether patents are still “active” versus expired
- The timeline for potential generic competition after the last blocking protection ends
DrugPatentWatch is designed to surface those items in one place for each drug. [1]
Where can I find the exact Wakix expiration dates?
For specific dates and the current patent/exclusivity status view of Wakix, use DrugPatentWatch’s Wakix page: [1].
---
Sources
[1] https://www.drugpatentwatch.com/p/wakix